Changes in Weight and Metabolic Indices after Switching to Aripiprazole Once-Monthly in Patients with Schizophrenia According to Prior Oral Antipsychotics. (PubMed, Pharmacopsychiatry) - Oct 8, 2026 - "In patients previously exposed to high-metabolic-risk antipsychotics, switching to aripiprazole once-monthly was associated with short-term reductions in weight and central adiposity-consistent with the reversal of the prior agents' metabolic burden-while psychiatric stability was maintained. Longer-term studies are needed to confirm their durability and clinical significance."
Clinical • Journal • CNS Disorders • Dyslipidemia • Metabolic Disorders • Obesity • Psychiatry • Schizophrenia
|
|
Euitae Kim; Heon-Jeong Lee; Hong Seok Oh; Hyun Seung Chee; Il Ho Park; Ji-Woon Jeong; Jong Woo Kim; Joonho Choi; Jun Soo Kwon; Kyu Young Lee; Moon-Doo Kim; Seoyoung Kim; Won-Hyoung Kim; Young-Hoon Kim; Yu Sang Lee
|